Butyrfentanyl
Discover related
2 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Also known as | bf | — | |
| Safety | |||
| Dose · Oral | |||
| Light | 400–800 µg | — | |
| Common | 800–1500 µg | — | |
| Strong | 1.5–3 µg | — | |
| Duration | |||
| After-effects | 1–4 hours | — | |
| Pharmacology | |||
| Half-life | — | Data for the half life of butyrfentanyl are not readily available. | |
| Protein binding | — | Protein binding studies for butyrfentanyl have not been performed but due to its structural similarity with fentanyl it is likely highly bound to serum albumin and alpha-1-acid glycoprotein in circulation. | |
TripSit summary
Potent short-acting opioid and fentanyl analogue. Often dispensed in a nasal spray. This is an highly potent drug - exercise extreme caution. May cause respiratory depression and death in overdose.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.